calcipotriene NDC 51862-512

NDC codes

FDA NDC Directory

Product NDC (as listed)51862-512Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51862-0512Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51862-512-60	51862051260	1 CAN in 1 CARTON (51862-512-60) / 60 g in 1 CANMarketed from Feb 15, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): calcipotriene
Generic name (nonproprietary): calcipotriene
Active ingredients: Calcipotriene — 50 ug/g
Dosage form: Aerosol, Foam
Route: Topical
Labeler: Mayne Pharma
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022563
Marketing start: Feb 15, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Vitamin D (Chemical structure)
Identifiers: Product ID 51862-512_8200e8ca-3486-4e51-8a3c-6efee8913d50SPL ID 8200e8ca-3486-4e51-8a3c-6efee8913d50SPL set ID 26756ac7-a80c-49db-97bb-351f76ad8a71RxCUI 1020035UNII 143NQ3779B
Pharmacologic class: Vitamin D Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451862051260 followed by a unit qualifier and the quantity

Package 51862-0512-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 9, 2024.

Indications (excerpt from the label)

Calcipotriene foam is indicated for the topical treatment of plaque psoriasis of the scalp and body in adults and pediatric patients 4 years of age and older. Calcipotriene foam, is a vitamin D analog indicated for the topical treatment of plaque psoriasis of the scalp and body in adults and pediatric patients 4 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 022563

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022563
Product	Strength	Form · route	Labeler	Product NDC
Soriluxcalcipotriene	Calcipotriene 50 ug/g	Aerosol, FoamTopical	Mayne Pharma	51862-376